We present two to five year patency rates of 59 femoropopliteal bypasses performed with stabilized human umbilical vein (SHUV). Strict adherence to precise technique is emphasized. Our overall patency rate calculated by the actuarial life table method was 54.5% at five years. Patients operated upon for limb salvage was 50% and in patients operated on for disabling claudication the rate was 65.6%. Properly utilized SHUV can provide patency rates in femoro popliteal bypass similar to those utilizing autologous saphenous vein and better than polytetrafluoroethylene, Dacron, and bovine heterograft when these are used for below knee anastomosis.
Get full access to this article
View all access options for this article.
References
1.
Hirsch SA: Arterial reconstruction of the lower limbs using stabilized human umbilical vein. J Vas Surg14:168-174, 1980.
2.
Dardik H., Ibrahim IM, Dardik II: Glutareldehydehyde-tanned umbilical cord vein: clinical assessment for arterial reconstruction in the lower extremities. In: Vascular Graft Symposium, the First National Institute of Grafts. Ed. by Sawyer P, Kaplitt M.New York, Appelton-Century and Crofts, 1976.
3.
Hirsch SA, Jarrett F.: Technique of femoropopliteal and femorotibial grafts using umbilical vein . Surg Gynecol Obstet155:246-249, 1982.
4.
Dardik H., Bair RE, Meenaghan M., et al: Morphologic and biophysical assessment of long term human umbilical cord vein implants used as vascular conduits. Surg Gynecol Obstet154:17-26, 1982.
5.
Walden R., L'Italian GJ, Megerman J, Abbott WM: Matched elastic properties and successful arterial grafting. Arch Surg115:1166-1169, 1980.
6.
Shah RR, Spinazzola AJ, King JN: Clinical experience with expanded polytetrafluoroethylene (Goretex) grafts for femoropopliteal arterial bypass. Am J Surg139:330-331, 1980.
7.
Evans LE, Webster MM, Brooks DH, et al: Expanded polytetrafluoroethylene femoropopliteal grafts: 48 month follow-up. Surgery89:16-22, 1981.
8.
Hallit Jr JW , Brewster DC, Darling RC: The limitations of polytetrafluoroethylene in the reconstruction of femoropopliteal and tibia arteries. Surg Gynecol Obstet152:819-821, 1981.
9.
Julian TB, Loubeay J., Stremple JF: Polytetrafluoroethylene or saphenous vein as a femoropopliteal bypass graft ? J Surg Reas32:1-6, 1982.
10.
Yasher JJ, et al: Dacron versus vein for femoropopliteal arterial bypass. Arch Surg116:1037-1040, 1981.
11.
Rosenberg N. , Thompson JE, Keshishian JM, et al: The modified bovine arterial graft . Arch Surg111:222-226, 1976.
12.
LaSalle AJ, Brewster DC, Corson JD, et al: Femoropopliteal composite bypass grafts: current status. Surgery92:36-39, 1982.
13.
Eickhoff JH , Buchardt Hansen HJ, Broome A., et al: A randomized clinical trial of PTFE versus human umbilical vein for femoropopliteal bypass surgery. Preliminary results. Brit J Surg70:85-88, 1983.
14.
Mulherin Jr JL, Edwards WH: The current status of femoropopliteal bypass grafting. Am Surg46:273,-277, 1980.
